NCT01795690已完成不适用
Clinical Registry Describing Treatment Reality of Patients With Cancer-(Therapy)-Induced Anemia
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- iOMEDICO AG
- 入组人数
- 1,018
- 试验地点
- 1
- 主要终点
- Documentation of therapies
研究概览
简要总结
The purpose of this registry is to record information of routine treatment of anemia in cancer patients in Germany. An overview of the current treatment of anemia in German outpatient centers and hospitals will be provided. Primary outcome parameters, e.g. improvement in hemoglobin levels and changes in QoL, as well as patient characteristics of different treatments will be analyzed.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Histologically confirmed malignant disease
- •Hemoglobin level < 11 g/dl (female) or < 12 g/dl (male)
- •Start of antianemic therapy no more than 7 days prior to informed consent
- •Performance status 0 - 3 (Karnofsky-Index >= 40%)
- •Minimum age: 18 years
- •Informed written consent
排除标准
- •Hypersensitivity against antianemic therapies
- •Myelodysplastic Syndrome
- •Experimental antianemic therapy
结局指标
主要结局
Documentation of therapies
时间窗: 12 weeks per patient
Overview on the current routine treatment of anemia in cancer patients in Germany
次要结局
- Change in hemoglobin levels and QoL(12 weeks per patient)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Tumor Registry Pancreatic CancerPancreas CancerNCT02089269iOMEDICO AG2,325
已完成
不适用
Tumor Registry of Advanced Renal Cell CarcinomaRenal Cell CarcinomaNCT00610012iOMEDICO AG1,500
已完成
不适用
Tumour Registry Breast CancerBreast CancerNCT01351584iOMEDICO AG4,500
已完成
不适用
Tumor Registry of Lymphatic NeoplasiaNon-Hodgkin's Lymphoma (NHL)Chronic Lymphocytic Leukemia (CLL)Multiple Myeloma (MM)NCT00889798iOMEDICO AG3,795
已完成
不适用
Epidemiological EMESIS-RegistryAntiemetic TherapyNCT00911222iOMEDICO AG1,035